To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer

Clinical trial NCT02476968 · COMPLETED

Trial details

NCT number: NCT02476968
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

BRCA or HRR+ Mutated Ovarian Cancer Patients

Start date: 2015-09-28
Primary completion: 2020-04-17
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.